Clinical and programmatic considerations in the treatment of MDR-TB in children: a series of 16 patients from Lima, Peru.
Mukherjee J, Joseph J, Rich M, Shin S, Furin J, Seung K, Sloutsky A, Socci A, Vanderwarker C, Vasquez L, Palacios E, Guerra D, Viru F, Farmer P, Del Castillo H. Clinical and programmatic considerations in the treatment of MDR-TB in children: a series of 16 patients from Lima, Peru. The International Journal Of Tuberculosis And Lung Disease 2003, 7: 637-44. PMID: 12870684.Peer-Reviewed Original ResearchConceptsMultidrug-resistant tuberculosisPediatric MDR-TBMonths of therapySecond-line anti-tuberculosis drugsIntermediate outcomesFavorable clinical evolutionShort-course strategyAnti-tuberculosis drugsDOTS-PlusRespiratory insufficiencyRadiographic evidenceClinical evolutionObserved treatmentCase definitionChronic illnessClinical failureCommon causeEarly diagnosisTherapySuch childrenChildrenPatientsTreatmentTuberculosisProgrammatic considerations